Iranian Journal of Otorhinolaryngology

Iranian Journal of Otorhinolaryngology

Assessment of Human Leukocyte Antigen Differences between Smokers with Reinke’s Edema and Those with Laryngeal Cancer

Document Type : Original

Authors
Farzad Izadi 1
Aslan Ahmadi 1
Farideh Hosseinzadeh 1
Marjan Mirsalehi 1
Yadollah Shakiba 2
Mohammad Ali Bahar 3
Maryam Balali 1
1 ENT and Head and Neck Research Center, the five Senses Health Institute, School of Medicine, Iran University of Medical Sciences.
2 Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3 Department of Immunology, Iran University of Medical Sciences, Tehran, Iran.
10.22038/ijorl.2022.52799.2797
Abstract
Introduction:
The present study aimed to assess human leukocyte antigen (HLA) typing differences between smokers with Reinke’s edema and those with laryngeal squamous cell carcinoma (SCC).
 
Materials and Methods:
The HLA class I, II alleles were examined in 76 unrelated Iranian patients using low-resolution polymerase chain reaction with the sequence-specific primer (PCR-SSP) method.
 
Results:
The frequency of the HLA-A*36 allele and HLA-B*35 was significantly higher in patients with SCC. The frequency of HLA-DRB1*01 alleles in Reinke’s edema was significantly higher, as compared to that in others. In the volunteer group, HLA-DRB1*13 and HLA-DRB1*15 were significantly higher.
 
Conclusions:
As evidenced by the obtained results, HLA-A*36 was significantly higher in SCC, as compared to that in volunteers and Reinke’s edema patients. It can be concluded that being positive for HLA-A*36 increases the chance of SCC by three times. This result should be further investigated in cohort studies conducted on larger samples. Furthermore, HLA-A*24 was significantly higher in the volunteer group, as compared to that in other groups. The HLADRB1*01 was remarkably higher in Reinke’s edema, as compared to that in SCC.
Keywords
Human leukocyte antigen
Hypertrophic edema
Iranian
Polymerase chain reaction sequence-specific primers
Reinke’s edema
  1. Nachalon Y, Alkan U, Shvero J, Yaniv D, Shkedy Y, Limon D, et al. Assessment of laryngeal cancer in patients younger than 40 years. The Laryngoscope. 2018;128(7):1602-5.
  2. Muscat JE, Wynder EL. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer. 1992;69(9):2244-51.
  3. Li X, Gao L, Li H, Gao J, Yang Y, Zhou F, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. The Journal of infectious diseases. 2012;207(3):479-88.
  4. Koskinen WJ, Brøndbo K, Dahlstrand HM, Luostarinen T, Hakulinen T, Leivo I, et al. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. Journal of cancer research and clinical oncology. 2007;133(9):673-8.
  5. Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, et al. Human papillomavirus in early laryngeal carcinoma. The Laryngoscope. 2009;119(8):1531-7.
  6. Coca–Pelaz A, Rodrigo JP, Takes RP, Silver CE, Paccagnella D, Rinaldo A, et al. Relationship between reflux and laryngeal cancer. Head & neck. 2013;35(12):1814-8.
  7. Watanabe T, Kaneko K, Sakaguchi K, Takahashi H. Vocal-fold vibration of patients with Reinke's edema observed using high-speed digital imaging. Auris Nasus Larynx. 2016;43(6):654-7.
  8. Hirano M, Bless D. Typical vibratory patterns in vocal pathologies and their clinical implications, recurrent laryngeal nerve paralysis. Videostroboscopic examination of the larynx Singular Publishing Group, Inc San Diego. 1993.
  9. Lopez-Nevot M, Esteban F, Ferron A, Gutierrez J, Oliva M, Romero C, et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. British journal of cancer. 1989; 59(2):221.
  10. Maleno I, López-Nevot M, Cabrera T, Salinero J, Garrido F. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Cancer Immunology, Immunotherapy. 2002; 51(7): 389-96.
  11. Fleischhauer K, Zino E, Mazzi B, Severini G, Benazzi E, Bordignon C. HLA‐A* 02 subtype distribution in Caucasians from northern Italy: identification of A* 0220. Tissue Antigens. 1996; 48(6):673-9.
  12. Eura M, Katsura F, Oiso M, Obata A, Nakano K, Masuyama K, et al. Frequency of HLA-A alleles in Japanese patients with head and neck cancer. Japanese journal of clinical oncology. 1999; 29(11): 535-40.
  13. Sikorska B, Danilewicz M, WAGROWSKA‐DANILEWICZ M. HLA‐DR expression is a significant prognostic factor in laryngeal cancer: A morphometric study. Apmis. 1999; 107(1‐6):383-8.
  14. Theocharis S, Konstantopoulos K, Bannis K, Zervast J. HLA-A and-B antigens and larynx carcinoma in Greeks. Upsala journal of medical sciences. 1997;102(3):133-6.
  15. Sipaul F, Birchall M, Corfield A. What role do mucins have in the development of laryngeal squamous cell carcinoma? A systematic review. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2011; 268(8): 1109-17.
  16. Garrido F, Cabrera T, Aptsiauri N. "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy. International journal of cancer. 2010;127(2):249-56.
  17. White JD, Johnson JA, Nam JM, Cranston B, Hanchard B, Waldmann TA, et al. Distribution of human leukocyte antigens in a population of black patients with human T-cell lymphotrophic virus type I-associated adult T-cell leukemia/lymphoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1996;5(11):873-7.
  18. Shaiegan M, Yari F, Abolghasemi H, Bagheri N, Paridar M, Heidari A, et al. Allele frequencies of HLA-A, B and DRB1 among people of Fars ethnicity living in Tehran. Iranian journal of blood and cancer. 2011;3(4):55-9.
  19. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Human immunology. 2007; 68(9): 79-88.
  20. Ghashghaie A, Alimoghaddam K, Ostadali MR, Khansari L, Sadraee M, Mirrasekhian E, et al. Allele frequencies of HLA class-I loci in the normal Iranian population. International journal of hematology-oncology and stem cell research. 2009:18-20.
  21. Chan PK, Cheung JL, Cheung TH, Lin CK, Tam AO, Chan DP, et al. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. International journal of cancer. 2006;118(6):1430-5.

 

  1. Gao J, Zhu C, Zhu Z, Tang L, Liu L, Wen L, et al. The human leukocyte antigen and genetic
    susceptibility in human diseases. Journal of Bio-X Research. 2019;2(3):112-20.
  2. Farjadian S, Naruse T, Kawata H, Ghaderi A, Bahram S, Inoko H. Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue antigens. 2004;64(5):581-7.
  3. Khazaei HA, Rezaei N, Aghamohammadi A, Amirzargar AA, Ghasemi K, Mirimoghaddam I, et al. Human leukocyte antigen profile of two ethnic groups in Southeast of Iran. Iranian journal of allergy, asthma, and immunology. 2007;6(4):223-4.
  4. Koike K, Dehari H, Shimizu S, Nishiyama K, Sonoda T, Ogi K, et al. Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma. Cancer science. 2020;111(5):1491-9.
  5. Samuels S, Spaans VM, Osse M, Peters LA, Kenter GG, Fleuren GJ, et al. Human Leukocyte Antigen-DR Expression is Significantly Related to an Increased Disease-Free and Disease-Specific Survival in Patients With Cervical Adenocarcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016;26(8):1503-9.
  6. Yari F, Sobhani M, Sabaghi F, Zaman-Vaziri M, Bagheri N, Talebian A. Frequencies of HLA-DRB1 in Iranian normal population and in patients with acute lymphoblastic leukemia. Archives of medical research. 2008;39(2):205-8.
  7. Arab M, Pourpak Z, Mohammadian S, Zare A, Shakiba Y, Shokouhi Shoormasti R, et al. The Frequency of Human Leukocyte Antigen Class I and II Alleles and the Relationship Between Haplotypes in Gilaks Population of Iran. Immunoregulation. 2019; 2(1):57-66.
  8. Amanzadeh A, Amirzargar AA, Mohseni N, Arjang Z, Aghamohammadi A, Shokrgozar MA, et al. Association of HLA-DRB1, DQA1 and DQB1 Alleles and Haplotypes with Common Variable Immunodeficiency in Iranian Patients. Avicenna journal of medical biotechnology. 2012; 4(2): 103-12.
Iranian Journal of Otorhinolaryngology
Volume 34, Issue 2
March and April 2022
Pages 95-105